These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8314474)

  • 1. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
    Métreau JM
    Gut; 1993; 34(2 Suppl):S112-3. PubMed ID: 8314474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis.
    Senturk H; Uzunalimoglu O; Batur Y; Simsek I; Mert A; Ozbay G; Cetinkaya H; Ersoz G; Tabak F; Akbaylar H; Akdogan M; Dokmeci A; Sonsuz A; Ozenirler S; Erden E; Tozum N
    Dig Dis Sci; 1997 Jul; 42(7):1438-44. PubMed ID: 9246043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
    Piazza M; Orlando R; Tosone G; Tiseo D; Conte MC; Minervini F; Santoro G; Scordino F; Vitale D
    Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
    De Bac C; Grimaldi F; Clementi C; Duca F; Livoli D; Taliani G
    Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up evaluation in HCV chronic hepatitis treated with alpha-2b interferon. A comparison of two protocols.
    Budillon G; Cimino L; Del Vecchio Blanco C; Mazzacca G; Iaquinto G; D'Ascoli B; Lampasi F; Di Sapio M; Mattera D; Sapio D [corrected to Di Sapio M]
    Ital J Gastroenterol; 1994; 26(1):16-20. PubMed ID: 8025301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C.
    Jouët P; Roudot-Thoraval F; Dhumeaux D; Métreau JM
    Gastroenterology; 1994 Mar; 106(3):686-90. PubMed ID: 7907073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
    Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
    Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with interferon alfa-2b in patients with chronic hepatitis caused by hepatitis C virus: predictive factors for the response, relapse and early development to cirrhosis after treatment].
    Pérez Roldán F; De Diego A; Casado M; Matilla A; Bañares R; García-Durán F; Salcedo M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1996 Sep; 88(9):609-15. PubMed ID: 8962775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group.
    Lin R; Roach E; Zimmerman M; Strasser S; Farrell GC
    J Hepatol; 1995 Nov; 23(5):487-96. PubMed ID: 8583134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?
    Lin R; Schoeman MN; Craig PI; Bilous M; Grierson J; McDonald JA; Batey RG; Farrell GC
    Aust N Z J Med; 1991 Jun; 21(3):387-92. PubMed ID: 1953524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
    Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
    Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
    Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
    Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-interferon 2b in the treatment of chronic hepatitis C: interim report of the first multicentre Australian trial.
    Lin R; Liddle C; Farrell GC
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():101-3. PubMed ID: 8359618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis.
    De Conca V; Mesiti S; Vallarino E; Mornese A; Dodero M
    Gut; 1993; 34(2 Suppl):S126. PubMed ID: 8314477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.
    Makris M; Preston FE; Triger DR; Underwood JC; Westlake L; Adelman MI
    Blood; 1991 Oct; 78(7):1672-7. PubMed ID: 1912556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged treatment of chronic C hepatitis by means of medium-high doses of recombinant alpha-2b interferon: an open study to evaluate response and long-term relapse.
    Benetti GP; Ramella G; Corbellini A; Lazza M; Rossi U; Macchi R; Vitaliani G; Merlini R
    Ital J Gastroenterol; 1996 Apr; 28(3):127-35. PubMed ID: 8789822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
    Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prednisolone pretreatment in interferon alfa therapy for patients with chronic non-A, non-B (C) hepatitis.
    Liaw YF; Sheen IS; Lin SM; Chen TJ; Chu CM
    Liver; 1993 Feb; 13(1):46-50. PubMed ID: 8455424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months.
    Pérez R; Pravia R; Linares A; González M; Rodríguez M; Lombraña JL; Riestra S; Suárez A; Rodrigo L
    Gut; 1993; 34(2 Suppl):S136-8. PubMed ID: 8314481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.